 |
 |
 |
 |
|
 |
Treatment Next 25
|
 |
Location |
 |
Last Updated |
 |
 |
 |
Details |
 |
A Phase 1b Study of AdV-tk + Valacyclovir Gene Therapy in Combination With Standard Radiation Therapy for Malignant Gliomas
|
 |
San Antonio, TX |
 |
01/24/2010 |
 |
 |
 |
 |
 |
Details |
 |
A Phase 2a Study of AdV-tk + Valacyclovir Gene Therapy in Combination With Standard Radiation Therapy for Malignant Glioma |
 |
Duarte, CA Chicago, IL Columbus, OH San Antonio, TX |
 |
01/24/2010 |
 |
 |
 |
Details |
 |
Phase I Study of Glioma-Associated Antigen (GAA) Peptide-Pulsed Dendritic Cell Vaccination in Malignant Glioma Patients |
 |
Los Angeles, CA |
 |
01/24/2010 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of GP96 Heat Shock Protein-Peptide Complex Vaccine in Patients With Recurrent or Progressive High-Grade Glioma |
 |
San Francisco, CA |
 |
01/24/2010 |
 |
 |
 |
Details |
 |
Phase ll Trial of Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Patients With Atypical or Malignant, Primary or Metastatic Brain Tumors of the Central Nervous System |
 |
Los Angeles, CA |
 |
01/24/2010 |
 |
 |
 |
 |
 |
Details |
 |
Phase I Dose Escalation Study of Autologous Antigen-Pulsed Dendritic Cell Immunotherapy for Malignant Gliomas (e.g. Glioblastoma Multiforme, Anaplastic Astrocytoma) |
 |
Los Angeles, CA Los Angeles, CA |
 |
01/24/2010 |
 |
 |
 |
Details |
 |
ABTC 04-03: A Phase I Study of Vorinostat (Suberolyanilide Hydroxamic Acid [SAHA]) in Combination with Temozolomide in Patients with Malignant Gliomas |
 |
San Francisco, CA |
 |
01/11/2010 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Spectroscopy for Target Definition in Patients with Recurrent Glioma |
 |
San Francisco, CA |
 |
01/11/2010 |
 |
 |
 |
Details |
 |
A Study of Bevacizumab (Avastin) Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas |
 |
Cincinnati, OH |
 |
01/03/2010 |
 |
 |
 |
 |
 |
Details |
 |
Phase I study of Vorinostat (SAHA) in combination with temozolomide in patiesnts with malignant gliomas |
 |
Houston, TX |
 |
12/03/2009 |
 |
 |
 |
Details |
 |
Phase I/II adaptive randomized trial of vorinostat, erlotinib and carboplatin in adults with recurrent glioblastoma |
 |
Houston, TX |
 |
12/03/2009 |
 |
 |
 |
 |
 |
Details |
 |
A Pilot Study to Evaluate the Effects of Vaccinations with HLA-A2-Restricted Glioma Antigen-Peptides in Combination with Poly-ICLC for Children with Newly Diagnosed Malignant or Intrinsic Brain Stem Gliomas (BSG) or Incompletely Resected Non-Brainstem High-Grade Gliomas (HGG) or Recurrent Unresectable Low-Grade Gliomas (LGG) or Recurrent High Grade Gliomas |
 |
Pittsburgh, PA |
 |
09/23/2009 |
 |
 |
 |
Details |
 |
Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor |
 |
Boston, MA |
 |
09/06/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas
|
 |
Durham, NC |
 |
09/05/2009 |
 |
 |
 |
Details |
 |
ABTC07-01-Phase I Trial of Aflibercept (VEGF Trap) with Radiation Therapy and Concomitant and Adjuvant
Temozolomide in Patients with Malignant Glioma |
 |
San Francisco, CA |
 |
07/07/2009 |
 |
 |
 |
 |
 |
Details |
 |
A Phase I Trial and Pharmacokinetic Study of Trabectedin (Yondelis®, ET-743) in Children and Adolescents With Relapsed or Refractory Solid Tumors
|
 |
Bethesda, MD |
 |
04/22/2009 |
 |
 |
 |
Details |
 |
A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Adults With Recurrent Gliomas
|
 |
Bethesda, MD |
 |
04/22/2009 |
 |
 |
 |
 |
 |
Details |
 |
A Phase I/II Trial of ZD6474 for Patients With Recurrent High-Grade and Progressive Low-Grade Gliomas
|
 |
Bethesda, MD |
 |
04/22/2009 |
 |
 |
 |
Details |
 |
Multiple Ascending Dose (MAD) Study of the IGF-1R Antagonist R1507 Administered as an Intravenous Infusion in Pediatric Patients With Advanced Solid Tumors.
|
 |
Bethesda, MD |
 |
04/22/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Trial of Tamoxifen and Bortezomib in Patients With Recurrent High-Grade Gliomas
|
 |
Bethesda, MD |
 |
04/22/2009 |
 |
 |
 |
Details |
 |
A Phase II Clinical Trial of the Histone Deacetylase Inhibitor Valproic Acid in Combination With Temodar and Radiation Therapy in Patients With High Grade Gliomas
|
 |
Bethesda, MD |
 |
04/21/2009 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II Trial of Bevacizumab (avastin) and Irinotecan (CPT-11) for Patients With Recurrent High-Grade Gliomas Immediately Following Tumor Progression After Treatment With Bevacizumab Alone: A Companion Trial to NCI Study 06-C-0064 (Bevacizumab Alone for Recurrent Gliomas)
|
 |
Bethesda, MD |
 |
04/21/2009 |
 |
 |
 |
Details |
 |
A Phase II Trial of Enzastaurin in Combination With Bevacizumab in Adults With Recurrent Malignant Gliomas
|
 |
Bethesda, MD |
 |
04/21/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Trial of Bevacizumab (Avastin)for Patients With Recurrent High-Grade Glioma |
 |
Bethesda, MD |
 |
04/21/2009 |
 |
 |
 |
Details |
 |
A Pharmacokinetic and Phase 2 Study of Sunitinib Malate in Recurrent Malignant Gliomas |
 |
Toronto, Ontario, CANADA Bethesda, MD New York, NY Cincinnati,, OH Columbus, OH |
 |
04/21/2009 |
 |
 |
 |
 |
 |